Skip to main content
Premium Trial:

Request an Annual Quote

Tecan and EMD Biosciences to Co-Market Proteomics Products

NEW YORK, July 15 -  Tecan and Merck affiliate EMD biosciences announced today a collaboration to co-market protein extraction, screening, and purification products.


Under the agreement, Tecan, of Männedorf, Switzerland, and EMD, of   Darmstadt, Germany, will sell a combination of EMD's Novagen-brand reagents for protein extraction and purification kits, and Tecan's Genesis and Freedom EVO liquid handling robots for protein purification. The companies have also formed an integrated technical applications team to support the products.


The companies said they have developed protocols designed to enable users of their technology to use vacuum filtration or magnetic bead separation to purify proteins in a 96-well plate, and to do recombinant protein expression and solubility screening assays.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.